Brief: Epigenomics Q2 Net Loss Shrinks To EUR 2.6 Mln
08/08/2018 07:16
Aug 8 (Reuters) - Epigenomics AG ECXn.DE :
* DGAP-NEWS: EPIGENOMICS AG ANNOUNCES 2018 SECOND QUARTER AND SIX MONTH FINANCIAL RESULTS
* TOTAL Q2 2018 REVENUE INCREASED TO EUR 0.5 MILLION (Q2 2017: EUR 0.2 MILLION)
* NET LOSS AMOUNTED TO EUR 2.6 MILLION IN Q2 2018 COMPARED TO EUR 4.1 MILLION IN Q2 2017
* OUTLOOK 2018 CONFIRMED
* ADJUSTED EBITDA IN Q2 2018 WAS AT EUR -2.2 MILLION (Q2 2017: EUR -3.4 MILLION)
Source text for Eikon: ID:nEQ7rMnBra
Further company coverage: ECXn.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns